# Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis

> **NCT00196755** · PHASE3 · COMPLETED · sponsor: **Genzyme, a Sanofi Company** · enrollment: 138 (actual)

## Conditions studied

- Peritoneal Dialysis
- Chronic Kidney Disease

## Interventions

- **DRUG:** Sevelamer Hydrochloride (Renagel®)
- **DRUG:** Calcium acetate (PhosLo® )

## Key facts

- **NCT ID:** NCT00196755
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2006-03
- **Final completion:** 2006-04
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2015-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00196755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00196755, "Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT00196755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*